Transfusion Molecular Testing
Bring innovative molecular tools to your lab to provide the closest match possible between a patient and a donor.
HEA BeadChipTM
Rapidly detect genotypes for the accurate prediction of phenotypes with our HEA BeadChipTM in-vitro diagnostic test and multiplexed molecular assay.
Increase Efficiency:
- Identifies the most relevant 35 red blood cell antigens plus three phenotypic variants from 11 blood groups
- Detects 24 gene mutations and one polymorphism associated with hemoglobinopathies (Sickle-cell Hemoglobin is not intended for the diagnosis of sickle cell disease)
Interpret Results Accurately:
- Automated array imaging
- Computerized data management using ImmuLINK®
RHD BeadChipTM
Comprehensive coverage for identifying more than 67 RH variant alleles.
Increase Efficiency in Your Lab
- Multiplex, simultaneous testing of a broad set of RH targets
- 96 tests complete within 5 hours post extraction with 1 hour of hands-on time
Interpret Results Accurately
- Automated array imaging
- Proprietary Bayesian algorithm for determining phenotype and RH variant from the genotype
RHCE BeadChipTM
Comprehensive coverage for identifying more than 44 RH variant alleles.
Increase Efficiency in Your Lab
- Multiplex, simultaneous testing of a broad set of RH targets
- 96 tests complete within 5 hours post extraction with 1 hour of hands-on time
Interpret Results Accurately
- Automated array imaging
- Proprietary Bayesian algorithm for determining phenotype and RH variant from the genotype
HPA BeadChipTM
Quickly Detect Human Platelet Antigens on a Large Scale
The HPA BeadChip is a high-throughput molecular assay that detects 22 human platelet antigens by multiplex DNA analysis.
Maximum Performance
- Perform extended typing of patients and donors without the need for actual platelets or rare typing sera
- Generate over 2000 results simultaneously across 22 platelet antigens in a single batch
- 96 Tests can be completed within 5 hours post extraction with only 1 hour of hands-on time
*Product offerings may differ by region, please check with your local Immucor representative for regulatory status in your area.
Resource Library
Our Certifications
Upcoming Events,
Webinars & Workshops
Keep Up With Us
News & Blogs
Werfen Completes Acquisition of Immucor, Inc.
WERFEN COMPLETES ACQUISITION OF IMMUCOR, INC., EXPANDING LEADERSHIP IN SPECIALIZED DIAGNOSTICS Werfen announced in November 2022 that it reached an agreement to acquire Immucor, Inc. for approximately US$2 billion. The transaction has received all necessary regulatory approvals. The Transfusion and...
